405 filings
Page 11 of 21
424B3
ypr80n9d
16 Mar 22
Prospectus supplement
4:11pm
8-K
ukaodbi3xmhg881
16 Mar 22
Other Events
4:06pm
4
ouizs3mwuqqwnswnuh
15 Mar 22
Change in insider ownership
5:40pm
424B3
3l2k9s11bk
1 Mar 22
Prospectus supplement
4:51pm
8-K
i1fprieb4083l49
1 Mar 22
Entry into a Material Definitive Agreement
4:47pm
424B3
9f63odfkc4en
16 Feb 22
Prospectus supplement
8:36am
8-K
go5wz8vkoa hmbrrr89
16 Feb 22
Other Events
8:31am
SC 13G/A
upksxmb
4 Feb 22
Celularity / Weiss Asset Management ownership change
12:07pm
SC 13G/A
fbl3vlg0
27 Jan 22
Celularity / HIGHBRIDGE CAPITAL MANAGEMENT ownership change
8:13am
424B3
i4jegvm42gr
18 Jan 22
Prospectus supplement
4:11pm
8-K
uoud43r 8bq0x4
18 Jan 22
Other Events
4:06pm
424B3
pzkkemqug2
28 Dec 21
Prospectus supplement
4:05pm
8-K
eo62zivwua1yv3
28 Dec 21
Celularity Receives Fast Track Designation from U.S. FDA for its NK Cell Therapy CYNK-001 in Development for the Treatment of AML
4:01pm
424B3
rc9s2gg6hy9kraab4th
17 Dec 21
Prospectus supplement
8:35am
8-K
9e71j8rcv
17 Dec 21
Other Events
8:30am
4
5g39uq9le9a
2 Dec 21
Celularity / ESCHENBACH ANDREW C. VON ownership change
9:44pm
424B3
19ag6ngp1w2lyq wiq
12 Nov 21
Prospectus supplement
4:45pm
8-K
31zzz0r5 qc8k62
12 Nov 21
Celularity Reports Third Quarter 2021 Financial Results and Corporate Update
4:19pm